United States · FDA National Drug Code directory
budesonide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70771-1075_bfde9c2e-2ff5-4258-91bc-78a48b228d14
- Product NDC
- 70771-1075
- Form
- CAPSULE, COATED PELLETS
- Composition / generic term
- budesonide
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170608
- Source listing expiry
- 20261231
Source-listed ingredients
- BUDESONIDE — 3 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 CAPSULE, COATED PELLETS in 1 BOTTLE (70771-1075-0) · 70771-1075-0
- 100 CAPSULE, COATED PELLETS in 1 BOTTLE (70771-1075-1) · 70771-1075-1
- 30 CAPSULE, COATED PELLETS in 1 BOTTLE (70771-1075-3) · 70771-1075-3
- 10 BLISTER PACK in 1 CARTON (70771-1075-4) / 10 CAPSULE, COATED PELLETS in 1 BLISTER PACK · 70771-1075-4
- 500 CAPSULE, COATED PELLETS in 1 BOTTLE (70771-1075-5) · 70771-1075-5
- 90 CAPSULE, COATED PELLETS in 1 BOTTLE (70771-1075-9) · 70771-1075-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →